Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New Pain Management Regimen for Oocyte Pick-Up
2025-523018-10-00Phase 4Authorised
- Sponsor
- UZ Brussel
- Start
- Jan 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sufentanil, midazolam, lidocaine, alprazolam, Elfenor and 1 more, sponsored by UZ Brussel. Primary endpoint: Overall intra-procedural pain intensity during oocyte pick-up. Planned start Jan 2026; status: authorised.
02
Drugs
sufentanilmidazolamlidocainealprazolamElfenor
Beyond the preview
Go deeper on 2025-523018-10-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523018-10-00.